πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 127 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11285215

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11285214

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11285213

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11266657

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11219626

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11207328

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11207327

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11185550

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11185547

Use of reboxetine to treat narcolepsy

AXSOME THERAPEUTICS, INC. Β· Granted Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11179352

Dosage forms and methods for enantiomerically enriched or pure bupropion

AXSOME THERAPEUTICS, INC. Β· Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11179351

Dosage forms and methods for enantiomerically enriched or pure bupropion

AXSOME THERAPEUTICS, INC. Β· Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11135295

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11135226

Use of reboxetine to treat narcolepsy

AXSOME THERAPEUTICS, INC. Β· Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11129826

Bupropion as a modulator of drug activity

AXSOME THERAPEUTICS, INC. Β· Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11129895

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11123431

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11123344

Bupropion as a modulator of drug activity

AXSOME THERAPEUTICS, INC. Β· Granted Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11110173

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11077117

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11045549

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11020483

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11020402

Use of reboxetine to treat narcolepsy

AXSOME THERAPEUTICS, INC. Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11013806

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11013805

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted